Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ScleroBiotique: Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients

NCT04132206 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT04132206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04132206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ScleroBiotique: Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
Lead sponsor
Hôpital Européen Marseille
Phase
Observational
Overall status
Recruiting
Start date
October 8, 2019
Completion date
June 3, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis